[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.247.205. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 25, 2001

Safety of Bolus vs Infusion Thrombolytic Therapy

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;285(16):2075. doi:10.1001/jama.285.16.2075

To the Editor: In their meta-analyses1,2 Dr Eikelboom and colleagues compare thrombolytic therapies for acute myocardial infarction (MI). Since meta-analyses of bolus-vs-infusion trials reveal no differences in efficacy, the choice of agent should be based on safety and cost. With regard to safety, the only statistically significant difference in the meta-analyses was a reduction in intracranial hemorrhages with infusion agents.1,2

First Page Preview View Large
First page PDF preview
First page PDF preview
×